º£½ÇÖ±²¥

Welcome to the º£½ÇÖ±²¥-Fudan Symposium on Precision Microbiology, a premier collaboration between º£½ÇÖ±²¥ and the Institute of Infection and Health (IIH) at Fudan University. Following the success of our global series, this 2026 summit serves as a high-impact catalyst for the next era of microbial science. The symposium will take place from Nov. 13-16, 2026, at School of Management (Zhengli Campus), Fudan University in Shanghai.  

At the confluence of molecular biology, advanced computation and clinical practice, this symposium explores how precision microbiology is transforming our understanding of both pathogens and commensals alike. From host-microbe interactions to leveraging AI-driven data science, we will examine how these breakthroughs are being translated into next-generation diagnostics and therapeutics to solve the most pressing challenges in human health and infectious disease.  

Conference Dates: Nov. 13-16, 2026 

Questions? Please email china@asmusa.org.

Important Dates

Dates/times follow China Standard Time (CST, UTC+08), with all deadlines set for 11:59 p.m. CST.

Registration & Abstract Submission Open:?July 3, 2026? 
Registration Payment Opens: Mid-July
Abstract Submission Closes:?Sep. 28, 2026? 
Notification of Acceptance:?Oct.?12, 2026? 
Early Registration Closes: Oct. 15, 2026
Registration Closes:?Nov.?2, 2026 
Conference Dates:?Nov.?13-16, 2026? 

Molecular Mechanisms of Host–Microbe Interactions:

Exploring the biological processes that drive infection, immunity and disease.

• Mechanisms of pathogenesis.
• Host immune responses to infection.
• Microbial virulence and evolution.
• Host susceptibility and disease outcomes.
• Microbiome and host interactions in health and disease.

Next-Generation Diagnostics and Genomics:

Translating genomic discoveries into faster, more accurate diagnostic tools.

• Metagenomics and advanced sequencing technologies.
• Functional genomics in infectious diseases.
• Biomarker discovery and validation.
• Translating molecular insights into clinical diagnostics.

AI, Data Science and Systems Microbiology:

Harnessing AI and computation to transform microbiology research.

• Multi-omics integration and systems biology.
• AI-driven discovery and analysis.
• Computational microbiology and bioinformatics.
• Predictive modeling of infectious diseases.
• Genomic epidemiology and infectious disease surveillance.

Translational Therapeutics and Clinical Implementation:

Clinical implementation of precision medicine in infectious disease.

• Antimicrobial resistance (AMR).
• Mechanism-based drug discovery and targets.
• Phage therapy and alternative therapeutics.
• Translating research into clinical practice.

Explore Past Symposiums in China

Established in 1905 as the first Chinese-founded institution of higher learning, Fudan University has evolved into a global academic powerhouse. Following its pivotal merger with Shanghai Medical University in 2000, the institution now spans 12 diverse disciplines, with 5 core fields—natural sciences, medicine, engineering, humanities and social sciences—ranking among the world’s top 100 academic institutions. Ranked 30th globally and 3rd in mainland China, Fudan maintains a vast international footprint through partnerships with over 400 institutions across 53 countries. With 17 affiliated hospitals and a commitment to "Double First-Class" excellence, Fudan continues to drive innovation and collaboration on a prestigious international stage. 

The Institute of Infection and Health (IIH) at Fudan University was established in September 2023, with Wenhong Zhang, M.D., Ph.D., as dean and Daru Lu, Ph.D., and Guanghua Huang, Ph.D., as associate deans. Serving as the core campus entity supporting the Guangzhou Laboratory Shanghai Base, IIH is clinically driven and aligned with national strategic priorities in microbiology and infectious diseases. The institute focuses on advancing the diagnosis, treatment and prevention of major infectious diseases while building infrastructure for clinical translation and emergency preparedness. IIH brings together research platforms spanning big data, vaccines, antibody engineering, microbial diagnostics and drug screening, with early outcomes already emerging in diagnostics and therapeutics. It maintains strategic partnerships with Fudan’s School of Life Science and the State Key Laboratory of Bioreactor Engineering at East China University of Science and Technology.

IIH aims to become a globally recognized center for pathogen research, clinical trials and innovation translation. The institute is committed to international collaboration and training, contributing to infectious disease control and pandemic preparedness. The º£½ÇÖ±²¥-Fudan Symposium reflects this shared vision—bringing together global scientific leaders to advance precision microbiology from discovery to clinical impact.